Sign in
Home
News
About Us
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Knox Daily
Opinion Matters
Home
News
About Us
Contact Us
Home
Tags
AKBA
Tag: AKBA
Analysts Viewpoint
A company insider recently sold 91,868 shares of Akebia Therapeutics Inc. [AKBA]. Should You Sale?
Anna Perez
-
March 24, 2023
0
Stock Earnings
AKBA (Akebia Therapeutics Inc.) may reap gains as insiders became active recently
Anna Perez
-
March 21, 2023
0
Insiders Updates
A company insider recently sold 91,868 shares of Akebia Therapeutics Inc. [AKBA]. Should You Sale?
Samantha Gray
-
March 16, 2023
0
Analysts Viewpoint
The Potential Rise in the Price of Akebia Therapeutics Inc. (AKBA) following insiders activity
Daniel Torres
-
March 13, 2023
0
Analysts Viewpoint
Insider Selling: Butler John P., Akebia Therapeutics Inc. [AKBA] CEO and President divested 91,868 shares
Anna Perez
-
March 9, 2023
0
Analysts Viewpoint
The Potential Rise in the Price of Akebia Therapeutics Inc. (AKBA) following insiders activity
Jaxson Clark
-
March 6, 2023
0
![A company insider recently sold 91,868 shares of Akebia Therapeutics Inc. [AKBA]. Should You Sale?](https://knoxdaily.com/wp-content/uploads/2020/09/pen-4337524_640.jpg "A company insider recently sold 91,868 shares of Akebia Therapeutics Inc. [AKBA]. Should You Sale?")
![A company insider recently sold 91,868 shares of Akebia Therapeutics Inc. [AKBA]. Should You Sale?](https://knoxdaily.com/wp-content/uploads/2020/08/house-1353389_640.jpg "A company insider recently sold 91,868 shares of Akebia Therapeutics Inc. [AKBA]. Should You Sale?")
![Insider Selling: Butler John P., Akebia Therapeutics Inc. [AKBA] CEO and President divested 91,868 shares](https://knoxdaily.com/wp-content/uploads/2020/08/sponsor-5200336_640.jpg "Insider Selling: Butler John P., Akebia Therapeutics Inc. [AKBA] CEO and President divested 91,868 shares")
